Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
J. Clin. Oncol 2022 Apr 11;[EPub Ahead of Print], N Li, Y Zhang, J Wang, J Zhu, L Wang, X Wu, D Yao, Q Wu, J Liu, J Tang, R Yin, G Lou, R An, G Zhang, X Xia, Q Li, Y Zhu, H Zheng, X Yang, Y Hu, X Zhang, M Hao, Y Huang, Z Lin, D Wang, X Guo, S Yao, X Wan, H Zhou, L Yao, X Yang, H Cui, Y Meng, S Zhang, J Qu, B Zhang, J Zou, L WuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.